Today’s Top Three in Pharma 021309 posted on February 13, 2009Promising no more: drug candidates fail - ViroPharma lost more than half its value in Nasdaq trading after experimental drug maribavir failed in tests on patients receiving bone-marrow transplants. …Continue Reading about Today’s Top Three in Pharma 021309 →